ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 210717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 210717; 2) Community: the network communities that were significantly associated with the response to NSC 210717; 3) Molecule: the relationships between components within communities and NSC 210717; 4) MDR: the compounds that were significantly associated with the NSC 210717.

NSC Compound Enrichment Correlation
NSC 736065 2-(4-Trifluoromethoxy-benzenesulfonylimino)-imidazolidine-1- carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester 0.048939380959983 0.11142878
NSC 740524 6-(3-Azidopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.048939380959983 0.4407518
NSC 740618 (Z)-1-(2-chloro-5-(trifluoromethyl)phenyl)-4-(2-hydroxybenzylidene)-2-phenyl-1H-imidazol-5(4H)-one 0.048939380959983 0.13289133
NSC 743884 Null 0.048939380959983 0.18159289
NSC 744209 Null 0.048939380959983 0.46594783
NSC 759630 LANATOSIDE C 0.048939380959983 0.3661946
NSC 94945 Questiomycin A 0.048939380959983 -0.058339783
NSC 116789 Acovenoside B 0.0489393809599837 0.37301728
NSC 1507 2-CHLORO-3-PHENOXY-1,4-NAPHTHOQUINONE 0.0489393809599837 0.051591182
NSC 200692 Aspiculamycin hydrochloride 0.0489393809599837 -0.12438039
Total:32  Current:31    [First] [Prev] [Next] [Last]